Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses

Post-exposure vaccination with vaccinia virus (VACV) has been suggested to be effective in minimizing death if administered within four days of smallpox exposure. While there is anecdotal evidence for efficacy of post-exposure vaccination this has not been definitively studied in humans. In this stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Holechek, Susan A., Denzler, Karen L., Heck, Michael C., Schriewer, Jill, Buller, R. Mark, Legrand, Fatema A., Verardi, Paulo H., Jones, Leslie A., Yilma, Tilahun, Jacobs, Bertram L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2013
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3798613/
https://ncbi.nlm.nih.gov/pubmed/24147092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0077879
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge